Abstract
BackgroundActivating the Stimulator of Interferon Genes (STING) adaptor incites antitumor immunity against immunogenic tumors in mice, prompting clinical trials to test STING activators. However, STING signaling in the tumor microenvironment...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have